A new class of influenza drug has been shown effective against drug-resistant strains of the flu virus, according to a study led by University of British Columbia researchers.
A new class of influenza drug has been shown effective against drug-resistant strains of the flu virus, according to a study led by University of British Columbia researchers.
The University of British Columbia today officially opens the new Faculty of Pharmaceutical Sciences Building, a state-of-the-art learning and research facility that will enable UBC to graduate 224 new pharmacists per year by 2015 – a 47 per cent increase – and more than double the research space for drug discovery and health care innovation.
The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian technologies that will help combat cystic fibrosis (CF).
Premier Gordon Campbell and University of British Columbia President Prof. Stephen Toope led a groundbreaking ceremony for the new Pharmaceutical Sciences Building today.